IL305969A - שיטות ערכות והרכבים לאפיון תגובה אנטי דלקתית של מוצר - Google Patents

שיטות ערכות והרכבים לאפיון תגובה אנטי דלקתית של מוצר

Info

Publication number
IL305969A
IL305969A IL305969A IL30596923A IL305969A IL 305969 A IL305969 A IL 305969A IL 305969 A IL305969 A IL 305969A IL 30596923 A IL30596923 A IL 30596923A IL 305969 A IL305969 A IL 305969A
Authority
IL
Israel
Prior art keywords
characterizing
compositions
product
inflammatory response
methods kits
Prior art date
Application number
IL305969A
Other languages
English (en)
Inventor
Katie C Mowry
Kelly A Kimmerling
Miranda D Burnette
Mary Rose Kammer
Original Assignee
Organogenesis Inc
Katie C Mowry
Kelly A Kimmerling
Miranda D Burnette
Mary Rose Kammer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/215,921 external-priority patent/US20210311022A1/en
Application filed by Organogenesis Inc, Katie C Mowry, Kelly A Kimmerling, Miranda D Burnette, Mary Rose Kammer filed Critical Organogenesis Inc
Publication of IL305969A publication Critical patent/IL305969A/he

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2301—Interleukin-1 (IL-1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/25—Tumour necrosing factors [TNF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
    • C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL305969A 2021-03-23 2022-03-23 שיטות ערכות והרכבים לאפיון תגובה אנטי דלקתית של מוצר IL305969A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163164846P 2021-03-23 2021-03-23
US17/215,921 US20210311022A1 (en) 2020-03-27 2021-03-29 Methods, kits and compositions for characterizing an anti-inflammatory response of a product
PCT/US2022/021614 WO2022204330A1 (en) 2021-03-23 2022-03-23 Methods kits and compositions for characterizing an anti-inflammatory response of a product

Publications (1)

Publication Number Publication Date
IL305969A true IL305969A (he) 2023-11-01

Family

ID=83396068

Family Applications (1)

Application Number Title Priority Date Filing Date
IL305969A IL305969A (he) 2021-03-23 2022-03-23 שיטות ערכות והרכבים לאפיון תגובה אנטי דלקתית של מוצר

Country Status (6)

Country Link
EP (1) EP4312597A1 (he)
JP (1) JP2024512060A (he)
AU (1) AU2022242840A1 (he)
CA (1) CA3213824A1 (he)
IL (1) IL305969A (he)
WO (1) WO2022204330A1 (he)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261239A1 (en) * 2004-05-23 2005-11-24 Universiteit Van Maastricht Use of ATP for the manufacture of a medicament for treating certain inflammatory conditions, oxidative stress and fatigue
CN102811736B (zh) * 2009-11-30 2016-01-20 生物测试股份公司 治疗系统性红斑狼疮(sle)的人源化抗il-10抗体
US8834928B1 (en) * 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same

Also Published As

Publication number Publication date
EP4312597A1 (en) 2024-02-07
AU2022242840A1 (en) 2023-09-28
WO2022204330A1 (en) 2022-09-29
JP2024512060A (ja) 2024-03-18
CA3213824A1 (en) 2022-09-29

Similar Documents

Publication Publication Date Title
EP3573623A4 (en) COMPOSITIONS AND METHODS OF INHIBITION OF GENE EXPRESSION OF FACTOR XII
EP3962296A4 (en) CANNABINOID COMPOSITIONS AND METHODS OF USE
EP3911338A4 (en) COMPOSITIONS AND METHODS FOR INHIBITION OF CELL LINE SPECIFIC ANTIGENS
EP4054621A4 (en) COMPOSITIONS AND METHODS FOR REPLACING RNA-ENCODED DNA ALLELES
EP3790594A4 (en) METHODS AND COMPOSITIONS FOR THE HOMOLOGY-DIRECTED REPAIR OF CAS ENDONUCLEASE-MEDIATED DOUBLE STRAND BREAKS
IL310291A (he) הרכבים ושיטות לעיכוב ras
EP3983378A4 (en) INHIBITORS OF THE INTEGRATED STRESS RESPONSE PATHWAY
EP3930697A4 (en) INTEGRATED STRESS RESPONSE PATHWAY INHIBITORS
EP3793562A4 (en) METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE
EP4164653A4 (en) MORPHIC FORMS OF TRILACICLIB AND METHODS OF PREPARING THE SAME
EP4021477A4 (en) METHOD FOR GENERATING AND ISOLATING MID-DOPAMINE NEURONS
EP3982949A4 (en) MRSA1 INHIBITORS
EP3930709A4 (en) LIPID PRODRUGS OF JAK INHIBITORS AND THEIR USES
EP3941927A4 (en) COMPOSITIONS AND METHODS FOR MODIFICATION OF TARGET MOLECULES
EP3700334A4 (en) COMPOSITIONS AND PROCESSES FOR THE PRODUCTION OF EXPANDED HEMATOPOIETIC STEM CELLS USING FLUORENE DERIVATIVES
EP4008123A4 (en) TIME OF ARRIVAL BASED PROCEDURE FOR EXTENDED CONNECTION RANGE
EP3841114A4 (en) METHODS AND COMPOSITIONS FOR RNA EXPRESSION OF MYC INHIBITORS
IL292086A (he) שיטות להכנה של זרע cannabis sativa נקבי ותכשירים שלו
IL305969A (he) שיטות ערכות והרכבים לאפיון תגובה אנטי דלקתית של מוצר
SG11202103965TA (en) Cyclodextrin-based formulation of a bcl-2 inhibitor
EP3981768A4 (en) POLYMORPH OF CDK9 INHIBITOR AND METHOD OF MANUFACTURE OF POLYMORPH AND USE THEREOF
EP4054330A4 (en) COMPOSITION AND ASSOCIATED METHODS OF PREPARATION AND USE
EP3773531A4 (en) A2-73 CRYSTALLINE POLYMORPHIC COMPOSITIONS OF MATERIAL AND THEIR METHODS OF USE
EP3687514A4 (en) METHODS AND COMPOSITIONS FOR INHIBITION OF STAT3
EP3793552A4 (en) ABHD12 INHIBITORS AND METHODS OF MAKING AND USE THEREOF